Skip to main content
. 2022 Sep 12;2022:6778332. doi: 10.1155/2022/6778332

Figure 1.

Figure 1

Met reduces RANKL-induced osteoclastogenesis by no cytotoxicity. (a) Chemical structure of Met. (b) The viability of cells unaffected by Met treatment at a concentration of 400 μM. (c) BMMs stimulated with specified concentrations of Met in osteoclastogenesis media (0, 200, and 400 μM), fixed, and stained with TRAP (p < 0.05, scar bar = 100 μm). The green arrows indicate TRAP-positive cells.